Log in to save to my catalogue

Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in anima...

Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in anima...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_26199414

Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer’s disease

About this item

Full title

Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer’s disease

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2015-08, Vol.112 (31), p.9734-9739

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Near-infrared fluorescence (NIRF) molecular imaging has been widely applied to monitoring therapy of cancer and other diseases in preclinical studies; however, this technology has not been applied successfully to monitoring therapy for Alzheimer’s disease (AD). Although several NIRF probes for detecting amyloid beta (Aβ) species of AD have been rep...

Alternative Titles

Full title

Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_26199414

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_26199414

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.1505420112

How to access this item